Fundraising Fox
/Companies
Sign in

Definigen

Uppsala, SE · 3 known investors

Find your way into Definigen

Each arrow is one introduction. Sign up to fill in the first one.

338 people can intro you to Jordi

Ask Rianne Ellenbroek to introduce you to Jordi Carreras-Puigvert

You →Rianne · together at Leiden University Medical Center →Jordi

152 people can intro you to Morgan

Ask Jamie Chen to introduce you to Morgan Ekmefjord

You →Jamie · together at Scaleout →Morgan

80 people can intro you to Ola

Ask Sam Okafor to introduce you to Ola Spjuth

You →Sam · together at Scaleout →Ola

Sign up to find every way you can get introduced to Definigen

  • Your email: who you already know at Definigen, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Definigen team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Founders & leadership

CTChristopher Trummer
Christopher TrummerCEO & Co-Founder
OSOla Spjuth
Ola SpjuthChief AI Officer (CAIO) & Co-FounderOla Spjuth leads a research group at Uppsala University focused on intelligent systems in drug discovery and toxicology, and is co-founder of Definigen, which manufactures iPSC-derived human hepatocytes for preclinical drug testing and disease modeling.
JCJordi Carreras-Puigvert
Jordi Carreras-PuigvertChief Scientific Officer & Co-FounderJordi Carreras-Puigvert is Chief Scientific Officer and Co-Founder of Definigen, which develops iPSC-derived human hepatocytes and intestinal organoids for drug safety testing and disease modeling. He holds an Associate Professor position at Uppsala University, where he co-leads the Pharmaceutical Bioinformatics group.
MEMorgan Ekmefjord
Morgan EkmefjordCo-Founder & CTOMorgan Ekmefjord is co-founder and CTO of Definigen, which manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling.

Investors · 3

Nordic Science Investments✓ confirmed by DefinigenHelsinki · $55K – $3.9M

How we know: the company's own site · Not right? Tell us

24 Haymarketlisted by 24 HaymarketLondon

Founder mafia

4 people who came through Definigen went on to found or lead other companies.

Jonathan MilnerInvestorFounded Bit BioOla SpjuthChief AI Officer (CAIO) & Co-FounderFounded PixlJordi Carreras-PuigvertChief Scientific Officer & Co-FounderFounded PixlMorgan EkmefjordCo-Founder & CTOFounded Pixl

Frequently asked questions

What does Definigen do?
Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.
Who founded Definigen?
Definigen was founded by Christopher Trummer, Ola Spjuth, Jordi Carreras-Puigvert, Morgan Ekmefjord.
Who are Definigen's investors?
Definigen's investors include Almi Invest, Nordic Science Investments, 24 Haymarket.
Where is Definigen headquartered?
Definigen is headquartered in Uppsala, SE.